Jonathan E Campbell Selected Research

Jonathan E Campbell Research Topics

Disease

15	Type 2 Diabetes Mellitus (MODY) 01/2023 - 06/2013
14	Body Weight (Weight, Body) 01/2023 - 09/2012
13	Obesity 12/2022 - 01/2012
11	Insulin Resistance 01/2022 - 05/2006
6	Hyperglycemia 01/2020 - 03/2007
5	Weight Loss (Weight Reduction) 01/2023 - 12/2022
4	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2023 - 12/2006
4	Inflammation (Inflammations) 01/2021 - 03/2016
4	Hypoglycemia (Reactive Hypoglycemia) 01/2020 - 12/2006
3	Weight Gain 01/2022 - 01/2020
2	Glucose Intolerance 10/2020 - 04/2017
2	Myocardial Infarction 01/2018 - 08/2014
2	Diabetes Mellitus 06/2015 - 03/2007
1	Fatty Liver 01/2023
1	Insulinoma 01/2021
1	Succinyl-CoA:3-oxoacid CoA transferase deficiency 01/2020
1	Pyruvate Dehydrogenase Complex Deficiency Disease 01/2020
1	Tics (Tic) 01/2020
1	Tourette Syndrome (Tourette's Syndrome) 01/2020
1	Ketosis 01/2020
1	Non-alcoholic Fatty Liver Disease 01/2020
1	Starvation 01/2019
1	Metabolic Diseases (Metabolic Disease) 10/2018
1	Overnutrition 01/2018
1	Cardiomegaly (Heart Hypertrophy) 03/2016
1	Heart Failure 03/2016
1	Fibrosis (Cirrhosis) 03/2016
1	Diabetes Complications 01/2015
1	Cardiomyopathies (Cardiomyopathy) 08/2014
1	Atherosclerosis 01/2013
1	Hyperinsulinism (Hyperinsulinemia) 09/2012
1	Bursitis (Adhesive Capsulitis) 09/2011
1	Hypertrophy 01/2011
1	Overweight 05/2009
1	Coma (Comas) 12/2006
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 05/2006

Drug/Important Bio-Agent (IBA)

23	Glucose (Dextrose)FDA LinkGeneric 01/2023 - 12/2006
9	Insulin (Novolin)FDA Link 11/2022 - 12/2006
8	Glucagon (Glukagon)FDA Link 01/2023 - 06/2015
6	Peptides (Polypeptides)IBA 01/2023 - 06/2013
6	IncretinsIBA 01/2023 - 06/2013
6	Glucagon-Like Peptide-1 ReceptorIBA 01/2023 - 01/2013
5	gastric inhibitory polypeptide receptorIBA 01/2022 - 01/2012
4	CarbohydratesIBA 01/2023 - 12/2006
4	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2021 - 06/2013
4	Hormones (Hormone)IBA 01/2021 - 06/2013
3	tirzepatideIBA 01/2023 - 01/2020
3	Glucagon Receptors (Glucagon Receptor)IBA 11/2022 - 01/2015
3	Proteins (Proteins, Gene)FDA Link 01/2020 - 05/2009
3	LipidsIBA 01/2020 - 01/2013
3	Streptozocin (Streptozotocin)FDA Link 11/2015 - 03/2007
3	GlucocorticoidsIBA 01/2012 - 05/2006
2	Dietary Carbohydrates (Carbohydrate, Dietary)IBA 01/2023 - 01/2023
2	fibroblast growth factor 21IBA 01/2023 - 01/2023
2	Liraglutide FDA Link 01/2023 - 01/2023
2	SugarsIBA 01/2023 - 01/2023
2	Blood Glucose (Blood Sugar)IBA 01/2023 - 01/2020
2	Leucine (L-Leucine)FDA Link 10/2020 - 04/2017
2	EnzymesIBA 01/2020 - 10/2017
2	Messenger RNA (mRNA)IBA 10/2019 - 03/2016
2	Doxorubicin (Adriamycin)FDA LinkGeneric 03/2016 - 08/2014
1	POEGMAIBA 01/2023
1	PolymersIBA 01/2023
1	Amino Acids FDA Link 01/2023
1	semaglutideIBA 12/2022
1	Neutralizing AntibodiesIBA 12/2022
1	tesaglitazarIBA 01/2022
1	Retinoic Acid Receptors (Retinoic Acid Receptor)IBA 01/2022
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2022
1	AcidsIBA 01/2021
1	Citric Acid (Citrate)FDA LinkGeneric 01/2021
1	Glutamine (L-Glutamine)FDA Link 01/2021
1	Tricarboxylic AcidsIBA 01/2021
1	Pimozide (Orap)FDA Link 01/2020
1	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2020
1	KetonesIBA 01/2020
1	Pyruvic Acid (Pyruvate)IBA 01/2020
1	CitrullineIBA 01/2020
1	Oxidoreductases (Dehydrogenase)IBA 01/2020
1	Small Interfering RNA (siRNA)IBA 10/2019
1	GhrelinIBA 01/2019
1	CytokinesIBA 01/2019
1	Sterol Esterase (Hormone-Sensitive Lipase)IBA 01/2018
1	Triglycerides (Triacylglycerol)IBA 01/2018
1	Sirtuin 3IBA 01/2018
1	AdipokinesIBA 01/2017
1	MK0626IBA 03/2016
1	Dipeptidyl-Peptidase IV InhibitorsIBA 03/2016
1	Peptide Receptors (Peptide Receptor)IBA 01/2015
1	Apolipoproteins E (ApoE)IBA 01/2013
1	Metformin (Glucophage)FDA LinkGeneric 01/2013
1	taspoglutideIBA 01/2013
1	Drinking WaterIBA 01/2013
1	CorticosteroneIBA 09/2012
1	Adrenal Cortex Hormones (Corticosteroids)IBA 09/2011
1	salicylhydroxamic acid (SHAM)IBA 01/2011
1	11-beta-Hydroxysteroid Dehydrogenase Type 1IBA 05/2006

Therapy/Procedure

7	Therapeutics 01/2023 - 12/2006
2	Injections 01/2023 - 09/2011
1	Glycemic Control 01/2015